20170625_Vesalius - CV
Research payments
$20,701,295
Through program year 2024, $20,701,295 in research payments was reported against 20170625_Vesalius - CV, across 739 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $5,873,866 | 256 |
| 2023 | Research | $9,786,506 | 231 |
| 2022 | Research | $5,040,924 | 252 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Brian Bergmark Boston, MA Named on 10 payments
- Alan Wiseman Bangor, ME Named on 8 payments
- Edward Portnay Stamford, CT Named on 8 payments
- Linda Bassett Shaftoe Rocky Mount, NC Named on 7 payments
- David Murdock Wausau, WI Named on 7 payments
- Walter Haught Huntsville, AL Named on 6 payments
- Steven Lupovitch Arlington Heights, IL Named on 6 payments
- Faiq Akhter Springfield, OH Named on 6 payments
- Michael Koren Jacksonville, FL Named on 6 payments
- Sharath Subramanian Saint Cloud, MN Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.